Caas Capital Management LP Codex Dna, Inc. Transaction History
Caas Capital Management LP
- $1.31 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding DNAY
# of Institutions
23Shares Held
10.8MCall Options Held
0Put Options Held
0-
Northpond Ventures, LLC9.84MShares$18.2 Million51.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA418KShares$773,8420.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny232KShares$429,9300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA83.6KShares$154,5870.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX67KShares$123,9500.0% of portfolio
About Codex DNA, Inc.
- Ticker DNAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,518,200
- Market Cap $54.6M
- Description
- Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...